Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-13 Sale | 2025-03-17 5:14 pm | Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO | 4,501 | $16.94 | $76,247 | 72,343 (Direct) | View |
| 2024-11-26 Purchase | 2024-11-27 4:39 pm | Neurogene Inc. | NGNE | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 48,770 | $25.83 | $1,259,623 | 1,717,127 (Indirect) | View |
| 2024-11-22 Purchase | 2024-11-25 9:29 pm | Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO | 24,000 | $20.48 | $491,400 | 76,844 (Direct) | View |
| 2024-11-22 Purchase | 2024-11-25 9:29 pm | Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer | 47,500 | $20.4 | $969,000 | 1,297,859 (Direct) | View |
| 2023-08-15 Purchase | 2023-08-17 5:08 pm | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 2,285,342 | $0.64038 | $1,463,487 | 5,617,469 (Indirect Direct) | View |
| 2023-08-11 Sale | 2023-08-14 4:06 pm | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Interim CFO, Prin Acct Off | 1,323 | $0.6184 | $818 | 21,637 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-26 Option Award | 2025-03-28 9:30 pm | N/A 2035-03-26 | Neurogene Inc. | NGNE | Cobb Stuart Chief Scientific Officer | 50,100 | $0 | 70,491 (Direct) | View |
| 2025-03-26 Option Award | 2025-03-28 9:29 pm | N/A 2035-03-26 | Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO | 142,300 | $0 | 214,643 (Direct) | View |
| 2025-03-26 Option Award | 2025-03-28 9:28 pm | N/A 2035-03-26 | Neurogene Inc. | NGNE | Jordan Julie Chief Medical Officer | 58,700 | $0 | 58,700 (Direct) | View |
| 2025-03-26 Option Award | 2025-03-28 9:27 pm | 2025-03-26 N/A | Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer | 167,400 | $0 | 1,417,759 (Direct) | View |
Ownership | 2024-11-27 4:36 pm | N/A N/A | Neurogene Inc. | NGNE | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner | 0 | $0 | 1,755,427 (Indirect) | View |
| 2024-06-14 Option Award | 2024-06-17 2:37 pm | N/A 2034-06-14 | Neurogene Inc. | NGNE | Woods Robert Keith Director | 7,700 | $0 | 7,700 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 2:37 pm | N/A 2034-06-14 | Neurogene Inc. | NGNE | PALEKAR ROHAN Director | 7,700 | $0 | 7,700 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 2:36 pm | N/A 2034-06-14 | Neurogene Inc. | NGNE | BAFFI ROBERT Director | 7,700 | $0 | 7,700 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 2:36 pm | N/A 2034-06-14 | Neurogene Inc. | NGNE | Noonberg Sarah B. Director | 7,700 | $0 | 7,700 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 2:35 pm | N/A 2034-06-14 | Neurogene Inc. | NGNE | Freedland Cory S. Director | 7,700 | $0 | 7,700 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-14 8:54 pm | N/A 2034-03-13 | Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer | 93,282 | $0 | 93,282 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-14 8:53 pm | N/A 2034-03-13 | Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO | 85,803 | $0 | 106,744 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-14 8:51 pm | N/A 2034-03-13 | Neurogene Inc. | NGNE | Cobb Stuart Chief Scientific Officer | 54,841 | $0 | 54,841 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 7:01 pm | N/A 2034-01-16 | Neurogene Inc. | NGNE | Woods Robert Keith Director | 15,400 | $0 | 15,400 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 6:58 pm | N/A 2034-01-16 | Neurogene Inc. | NGNE | PALEKAR ROHAN Director | 15,400 | $0 | 15,400 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 6:56 pm | N/A 2034-01-16 | Neurogene Inc. | NGNE | Noonberg Sarah B. Director | 15,400 | $0 | 15,400 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 6:53 pm | N/A 2034-01-16 | Neurogene Inc. | NGNE | Freedland Cory S. Director | 15,400 | $0 | 15,400 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 6:51 pm | N/A 2034-01-16 | Neurogene Inc. | NGNE | BAFFI ROBERT Director | 15,400 | $0 | 15,400 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 6:48 pm | N/A 2034-01-16 | Neurogene Inc. | NGNE | Jordan Julie Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
Ownership | 2023-12-26 6:16 pm | N/A N/A | Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO | 0 | $0 | 126,750 (Direct) | View |
Ownership | 2023-12-26 6:12 pm | N/A N/A | Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer | 0 | $0 | 1,314,558 (Direct) | View |
Ownership | 2023-12-26 6:10 pm | N/A 2030-10-15 | Neurogene Inc. | NGNE | BAFFI ROBERT Director | 0 | $0 | 11,642 (Direct) | View |
Ownership | 2023-12-26 6:05 pm | N/A 2030-10-15 | Neurogene Inc. | NGNE | Cobb Stuart Chief Scientific Officer | 0 | $0 | 74,226 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 6:43 pm | N/A N/A | Neurogene Inc. | NGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Former 10% Owner Director | 2,877,250 | $0 | 7,831,766 (Indirect) | View |
| 2023-10-05 Exercise | 2023-10-10 4:22 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 592,650 | $0 | 3,363,045 (Indirect) | View |
| 2023-08-10 Exercise | 2023-08-14 4:06 pm | N/A N/A | Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Interim CFO, Prin Acct Off | 5,000 | $0 | 21,637 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:03 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director | 50,000 | $0 | 50,000 (Indirect) | View |
| 2023-06-08 Option Award | 2023-06-09 4:28 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | SIMPSON TODD E Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:27 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | PALEKAR ROHAN Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:26 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:25 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | Lavelle Erin Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:24 pm | N/A 2033-06-07 | Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director | 25,000 | $0 | 25,000 (Direct) | View |